Form 8-K - Current report:
SEC Accession No. 0000950170-23-013681
Filing Date
2023-04-20
Accepted
2023-04-20 16:10:33
Documents
12
Period of Report
2023-04-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-20230420.htm   iXBRL 8-K 53666
  Complete submission text file 0000950170-23-013681.txt   167557

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evok-20230420_pre.xml EX-101.PRE 9459
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evok-20230420.xsd EX-101.SCH 2478
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evok-20230420_lab.xml EX-101.LAB 12806
6 EXTRACTED XBRL INSTANCE DOCUMENT evok-20230420_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 23833214
SIC: 2834 Pharmaceutical Preparations